Navigation Links
Instrumentation Laboratory Announces 'ILeader Panel' of Experts as Part of 50th Anniversary Program
Date:12/9/2008

- Four-Person Panel Now Accepting Speaking Engagements -

LEXINGTON, Mass., Dec. 9 /PRNewswire/ -- Instrumentation Laboratory (IL), a worldwide developer, manufacturer and distributor of in vitro diagnostic instruments, related reagents and services, has announced its newly-formed ILeader Panel of experts as part of the Company's "50 and Forward" program to celebrate its 50th anniversary in 2009.

The ILeader Panel is a board of IL employees who have been selected for their substantial experience and knowledge in their specific fields, as well as their contributions to the diagnostics industry. Members of the ILeader Panel are available as knowledge resources for the IVD community and press, and for conferences, forums, webcasts, roundtables and other discussion venues.

ILeader Panel Members: Brief Biographies

Dr. Paul D'Orazio, Director, Critical Care Analytical: Dr. D'Orazio has nearly 30 years of experience in the critical care industry, and at IL he is responsible for the development of analytical methodologies from proof of concept and technical feasibility to market launch for the critical care product line. Prior to joining IL 9 years ago, Dr. D'Orazio worked as a research scientist and supervisor of Sensor Technology for Bayer Diagnostics. He holds 12 patents in the field of chemical sensors and served on the boards of the AACC Critical and Point of Care Testing and Industry Divisions, and as a member of several CSLI committees. He is currently a member of the International Federation of Clinical Chemistry Committee on Selective Electrodes and Point of Care Testing and an Editorial Board member for Point of Care: The Journal of Near Patient Testing and Technology. In addition, Dr. D'Orazio is an ongoing contributor to many leading industry publications. He holds a BA in Chemistry from Washington and Jefferson College and a PhD in Analytical Chemistry from the State University of New York at Buffalo.

Dr. Sohrab Mansouri, Staff Scientist: Dr. Mansouri brings over 20 years of field experience to IL, where his focus has been the industry-leading GEM(R) family of critical care analyzers. As an expert in quality assurance processes, he was involved in the development of the Intelligent Quality Management (iQM(R)) systems, the industry standard for quality control, and its application to both the GEM Premier(TM) 3000 and GEM Premier 4000. Dr. Mansouri also developed numerous sensors and has written over 30 publications in the field and authored/coauthored seven patents for improving sensor performance and calibration and reagent stability. He received the 'Technical Innovation Award' from Mallinkckrodt Headquarters in 2002. Dr. Mansouri holds a BS and MSc in Chemical Engineering and a PhD in Chemical Engineering from the University of Michigan.

Dr. Mark Triscott, Vice President of R & D, Reagent Development: Dr. Triscott has been in Hemostasis R&D for more than 20 years, joining the executive group at IL in 2006. His work has been featured in over 20 peer-reviewed publications and chapters, and he has authored/coauthored three patents in U.S. and foreign filings. A member of several professional societies, with special training in various industry subjects, and an author/contributor to more than 50 published abstracts and invited presentations, Dr. Triscott holds a BS and PhD in Microbiology from the University of Queensland in Australia.

Stephen Trotta, Vice President of R & D, Instrument Development: Stephen Trotta has over 20 years of experience in advanced engineering development, specializing in the design and development of automated instrumentation in the areas of electrical, mechanical, software, optical and systems design. His experience spans automated test equipment development to instrument development of laboratory equipment for biotechnology and biomedical applications. At IL, he has held various leadership, technical and project roles, including the project management of the ACL TOP(R) Hemostasis Testing System. Trotta is an active member of the Institute of Electrical and Electronics Engineers. He holds a BS in Electrical Engineering from Worcester Polytechnic Institute and an MSc in Electrical Engineering from the University of Massachusetts.

To interview an ILeader Panel member, or to book an ILeader for a speaking engagement, contact IL's Sally McCraven at 781-861-4577 or smccraven@ilww.com.

About Instrumentation Laboratory

Instrumentation Laboratory (www.ilus.com), founded in 1959, is a worldwide developer, manufacturer and distributor of in vitro diagnostic instruments, related reagents and controls for use primarily in hospitals and independent clinical laboratories. The company's product lines include critical care systems, hemostasis systems and information management systems. IL's GEM(R) product offerings, part of the critical care line, include the new GEM Premier(TM) 4000 analyzer with Intelligent Quality Management (iQM(R)), GEM Premier 3000 analyzer, GEM OPL(TM), a portable whole blood CO-Oximeter and the GEM PCL Plus, a portable coagulation analyzer. IL's hemostasis portfolio includes the ACL TOP(R) Family of Hemostasis Testing Systems, fully automated, high-productivity analyzers, including the ACL TOP and the new ACL TOP 500 CTS. IL also offers the ACL ELITE(R) and ELITE PRO, other hemostasis analyzers and the HemosIL(R) line of reagents. IL is based in Lexington, Massachusetts.

The Instrumentation Laboratory logo, GEM, iQM, HemosIL, ACL TOP, ACL ELITE, Premier and GEM OPL are trademarks of Instrumentation Laboratory Company and/or one of its subsidiaries or parent companies, and may be registered in the United States Patent and Trademark Office and in other jurisdictions. All other product names, company names, marks, logos, and symbols are trademarks of their respective owners.


'/>"/>
SOURCE Instrumentation Laboratory
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Frost & Sullivan Recognizes Waters Corporation for Its Pioneering, High Customer Value Analytical Instrumentation Product, SYNAPT HDMS
2. Instrumentation Laboratory Receives Performance Award from Premier for Second Consecutive Year
3. Instrumentation Laboratory Launches ACL Top(R) 500 CTS Hemostasis Testing System
4. Beckman Coulter to Acquire Flow Cytometry Instrumentation Business From Dako
5. Instrumentation Laboratory Named Top of Class by Respiratory Care Managers
6. LABS Inc. Adds Dr. Carol Pancoska as Laboratory Director
7. Burroughs Wellcome Fund award creates new Ph.D. path linking laboratory and population sciences
8. QC Sciences™ Announces Innovative Solution to Reduce Laboratory Costs : The NuView System™ For Non-Gynecologic Cytology Affords Substantial Savings
9. Bone cancer treatment ineffective, despite promising laboratory data
10. World Laboratory Washing Machines Market to Reach $84.9 Million by 2012, According to New Report by Global Industry Analysts
11. Global Med Technologies(R), Inc.s Inlog Subsidiary Licenses Its Leading Laboratory Information System to Gabriel Martin Hospital of Saint-Paul de la Reunion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... Georgia (PRWEB) , ... March 28, 2017 , ... ... to its award-winning team. Ruel Williamson brings his extensive knowledge of appraisals, property ... a leader in the real estate valuation industry for more than 40 years. ...
(Date:3/28/2017)... Seattle, WA (PRWEB) , ... March 28, 2017 ... ... reach a 22% share of all holidays (IBT World Travel Trends Report). As ... physically challenging, include a range in temperatures, and prolonged sun exposure. In response, ...
(Date:3/28/2017)... ... 28, 2017 , ... Z-Medica, LLC, a leading developer and ... (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) to equip up to 1,000 ... efforts by the American College of Surgeons, U.S. Department of Defense, Department of ...
(Date:3/28/2017)... ... 28, 2017 , ... Award-winning medical group Allied Anesthesia today ... board chair for Orange County health care system CalOptima Friday. CalOptima announced its ... chair Mark Refowitz’s term, which runs through June 30 of this year, until ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... plans work, the Self-Funding Success website has recently developed and published an informational ... Plans ” was created based on common inquiries the site’s team of third ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... 28, 2017 RXi Pharmaceuticals Corporation (NASDAQ: ... that address significant unmet medical needs, today announced ... Japan Patent Office (JPO) for the composition of ... (CTGF) for the treatment or prevention of fibrotic ... and proliferative retinopathy (Japanese Patent #: 6060071).  This ...
(Date:3/28/2017)... , March 28, 2017 ... research with Cambridge ... Consortium   The Milner Therapeutics Institute today announces ... Elysium Health has committed significant investment for collaborative projects with ... next four years. This is the first major research investment ...
(Date:3/27/2017)... TEL-AVIV, Israel , March 27, 2017 /PRNewswire/ ... TASE: THXBY), a specialty clinical-stage pharmaceutical company specializing in the ... of its public offering in the ... Shares (ADSs), each ADS representing 40 ordinary shares ... per ADS. In addition, Therapix has granted the ...
Breaking Medicine Technology: